CnogaCare continues to be at the forefront of non-invasive glucose technology by striving to be innovative and with an excellent consumer experience.
Our latest new non-invasive product is a Smart Wearable Capsule scheduled to be released soon. 
The ‘Smart Wearable Capsule’ is a multi-sensor array that captures and processes optical, thermal, and electrical conductivity signals from the wrist. 

Cnoga first-generation technology has gone through extensive clinical trials and has been approved for marketing in Europe, China, Brazil, and Israel.
The Smart Capsule is based on Cnoga Medical's first-generation product called CoG - a non-invasive glucose meter.  
Cnoga first-generation product required a lengthy calibration process which presented an enormous challenge for the end consumers.
The new product version uses a cloud-based deep learning algorithm that is more advanced than the first generation of machine learning methodology. 
The ‘Smart Wearable Capsule’ technology was developed in a similar manner to face and voice recognition technology, Cnoga utilizes big data analytics as well as multi-sensors fusion input to create patient's unique blood chemistry profile. 
‘Smart Wearable Capsule’ measures an array of biometric parameters non-invasively such as blood Glucose, Blood Pressure, Oxygen saturation, Haemoglobin, RBS, Haematocrit and Temperature.
Cnoga Smart capsule can either be worn on a dedicated Cnoga’s wristband or easily connected to any smartwatch wristband for continuous non-invasive monitoring fully integrated into any telemedicine platform and mobile devices